These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 18463559)

  • 1. Prodrugs for the treatment of neglected diseases.
    Chung MC; Ferreira EI; Santos JL; Giarolla J; Rando DG; Almeida AE; Bosquesi PL; Menegon RF; Blau L
    Molecules; 2007 Mar; 13(3):616-77. PubMed ID: 18463559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs.
    de Araújo RV; Santos SS; Sanches LM; Giarolla J; El Seoud O; Ferreira EI
    Mem Inst Oswaldo Cruz; 2020; 115():e200229. PubMed ID: 33053077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DB-289 Immtech International.
    Yeates C
    IDrugs; 2003 Nov; 6(11):1086-93. PubMed ID: 14600842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
    Previti S; Di Chio C; Ettari R; Zappalà M
    Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
    Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
    Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges in antiparasitic drug discovery.
    Pink R; Hudson A; Mouriès MA; Bendig M
    Nat Rev Drug Discov; 2005 Sep; 4(9):727-40. PubMed ID: 16138106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endemic tropical diseases: comtemporary health problem due to abandoned diseases in the developing world].
    Ohta N
    Kansenshogaku Zasshi; 2006 Sep; 80(5):469-74. PubMed ID: 17073258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
    Njogu PM; Guantai EM; Pavadai E; Chibale K
    ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for neglected diseases: part I.
    Kaneko T
    Future Med Chem; 2011 Aug; 3(10):1235-7. PubMed ID: 21859296
    [No Abstract]   [Full Text] [Related]  

  • 11. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
    Yamada H; Hirabayashi F; Brünger C
    Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
    Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New prodrugs against tuberculosis.
    Mori G; Chiarelli LR; Riccardi G; Pasca MR
    Drug Discov Today; 2017 Mar; 22(3):519-525. PubMed ID: 27649942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral drug therapy for multiple neglected tropical diseases: a systematic review.
    Reddy M; Gill SS; Kalkar SR; Wu W; Anderson PJ; Rochon PA
    JAMA; 2007 Oct; 298(16):1911-24. PubMed ID: 17954542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies and paradigm for drug target discovery: a special focus on infectious diseases tuberculosis, malaria, leishmaniasis, trypanosomiasis and gastritis.
    Neelapu NR; Srimath-Tirumala-Peddinti RC; Nammi D; Pasupuleti AC
    Infect Disord Drug Targets; 2013 Oct; 13(5):352-64. PubMed ID: 24712675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprotozoal agents: How have they changed over a decade?
    Fernandes VS; da Rosa R; Zimmermann LA; Rogério KR; Kümmerle AE; Bernardes LSC; Graebin CS
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100338. PubMed ID: 34661935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Privileged Structures in the Design of Potential Drug Candidates for Neglected Diseases.
    Leite ACL; Espíndola JWP; de Oliveira Cardoso MV; de Oliveira Filho GB
    Curr Med Chem; 2019; 26(23):4323-4354. PubMed ID: 29065822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.